AI & Machine Learning
Apr 28, 2026
FDA to Accelerate Drug Trials Using Real-Time Data and AI
Apr 28, 2026
AI Summary
The FDA aims to reduce the duration of drug testing by enhancing oversight of clinical trials in real-time. This initiative is expected to improve the efficiency of bringing new medicines to market.
- The FDA is implementing measures to increase visibility into ongoing clinical trials.
- The goal is to shorten the time required for drug companies to test new medications.
- The use of real-time data and artificial intelligence will be central to this effort.
fdadrug trialsreal-time dataclinical trialsai